Found 8 matching trials
Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era
N/AThis retrospective real-world target trial emulation uses complete Czech na...
Location
Department of Pharmacology, Third Faculty of Medicine, Charles University
AGILE (Early Phase Platform Trial for COVID-19)
PHASE1The AGILE platform master protocol allows incorporation of a range of ident...
Location
Desmond Tutu Health Foundation
A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016)
PHASE1The purpose of this study is to evaluate the pharmacokinetics (PK) of N-hyd...
Location
Research Centers of America ( Hollywood ) ( Site 0002)
Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19
PHASE2This was a phase IIa, double-blind, placebo-controlled, randomized trial, d...
Location
Valley Clinical Trials, Inc.
COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers
PHASE1This is a First In Human study designed to assess the safety, tolerability ...
Location
Covance Leeds Clinical Research Unit
A Study to Evaluate Molnupiravir (MK-4482; MOV) in Participants With Severe Renal Impairment (MK-4482-003)
PHASE1This purpose of this study is to evaluate the plasma pharmacokinetics (PK) ...
Location
Velocity Clinical Research, Hallandale Beach ( Site 0005)
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
PHASE2Designed as a multi-center, randomized, double-blind, placebo-controlled st...
Location
Ronald Reagan UCLA Medical Center
A Study to Evaluate Molnupiravir Tablet Formulation Compared to the Molnupiravir Capsule Formulation in Healthy Adult Participants (MK-4482-011)
PHASE1The goal of the study is to learn what happens to different forms of molnup...
Location
QPS-MRA, LLC-Early Phase (Site 0002)